Lonza Group Ltd
Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics; Small Molecules; Cell & Gene; and Capsules & Health Ingredients segments. The Biologics segment engages in the contract develo… Read more
Market Cap & Net Worth: Lonza Group Ltd (LZAGF)
Lonza Group Ltd (PINK:LZAGF) has a market capitalization of $41.82 Billion ($41.82 Billion) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #512 globally and #410 in its home market, demonstrating a -9.03% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Lonza Group Ltd's stock price $596.13 by its total outstanding shares 70145551 (70.15 Million).
Lonza Group Ltd Market Cap History: 2015 to 2025
Lonza Group Ltd's market capitalization history from 2015 to 2025. Data shows growth from $9.85 Billion to $41.82 Billion (18.09% CAGR).
Lonza Group Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Lonza Group Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
6.40x
Lonza Group Ltd's market cap is 6.40 times its annual revenue
0.68x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
44.06x
Lonza Group Ltd's market cap is 44.06 times its annual earnings
359.02x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $10.59 Billion | $4.13 Billion | $301.00 Million | 2.56x | 35.19x |
| 2017 | $17.64 Billion | $5.11 Billion | $707.00 Million | 3.45x | 24.94x |
| 2018 | $17.55 Billion | $5.54 Billion | $559.00 Million | 3.17x | 31.40x |
| 2019 | $25.05 Billion | $5.92 Billion | $645.00 Million | 4.23x | 38.84x |
| 2020 | $43.85 Billion | $4.51 Billion | $869.00 Million | 9.73x | 50.46x |
| 2021 | $56.28 Billion | $5.41 Billion | $2.94 Billion | 10.40x | 19.12x |
| 2022 | $33.87 Billion | $6.22 Billion | $1.22 Billion | 5.44x | 27.88x |
| 2023 | $29.17 Billion | $6.72 Billion | $654.00 Million | 4.34x | 44.60x |
| 2024 | $42.56 Billion | $6.57 Billion | $636.00 Million | 6.47x | 66.92x |
| 2025 | $41.82 Billion | $6.53 Billion | $949.00 Million | 6.40x | 44.06x |
Competitor Companies of LZAGF by Market Capitalization
Companies near Lonza Group Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Lonza Group Ltd by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #91 globally with a market cap of $176.18 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #154 globally with a market cap of $120.38 Billion USD.
- Agilent Technologies Inc (NYSE:A): Ranked #657 globally with a market cap of $31.54 Billion USD.
- Natera Inc (NASDAQ:NTRA): Ranked #743 globally with a market cap of $27.18 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #91 | Thermo Fisher Scientific Inc | NYSE:TMO | $176.18 Billion | $470.00 |
| #154 | Danaher Corporation | NYSE:DHR | $120.38 Billion | $191.39 |
| #657 | Agilent Technologies Inc | NYSE:A | $31.54 Billion | $111.83 |
| #743 | Natera Inc | NASDAQ:NTRA | $27.18 Billion | $197.68 |
Lonza Group Ltd Historical Marketcap From 2015 to 2025
Between 2015 and today, Lonza Group Ltd's market cap moved from $9.85 Billion to $ 41.82 Billion, with a yearly change of 18.09%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $41.82 Billion | -1.75% |
| 2024 | $42.56 Billion | +45.91% |
| 2023 | $29.17 Billion | -13.89% |
| 2022 | $33.87 Billion | -39.81% |
| 2021 | $56.28 Billion | +28.34% |
| 2020 | $43.85 Billion | +75.05% |
| 2019 | $25.05 Billion | +42.70% |
| 2018 | $17.55 Billion | -0.46% |
| 2017 | $17.64 Billion | +66.51% |
| 2016 | $10.59 Billion | +7.55% |
| 2015 | $9.85 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Lonza Group Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $41.82 Billion USD |
| MoneyControl | $41.82 Billion USD |
| MarketWatch | $41.82 Billion USD |
| marketcap.company | $41.82 Billion USD |
| Reuters | $41.82 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.